Evidence map›Paper›PMID 37429690›Full record

ArticleBMJ open2023

What are the prognostic factors for the development of incontinence-associated dermatitis (IAD): a protocol for a systematic review and meta-analysis.

Julie Deprez, Jan Kottner, Alexandra Eilegård Wallin, Nils Ohde, Carina Bååth, Ami Hommel, Lisa Hultin, Anna Josefson, Dimitri Beeckman

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06978751 (Development of a Risk Assessment Tool for Incontinence-associated Dermatitis), which is not on this map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06978751 completednot on this mapstarted 2025, after this paper: background citation

Development of a Risk Assessment Tool for Incontinence-associated Dermatitis (IAD): a Cohort Study on the Predictive Performance of Risk Factors for IAD

TypeobservationalSponsorÖrebro University, SwedenRan2025 to 2026Enrolled271ConditionsIncontinence Associated Dermatitis
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Julie DeprezSwedish Centre for Skin and Wound Research (SCENTR), School of Health Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden julie.deprez@oru.se.ORCID 0000-0002-8396-6761
Jan KottnerSkin Integrity Research Group (SKINT), University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0003-0750-3818
Alexandra Eilegård WallinSwedish Centre for Skin and Wound Research (SCENTR), School of Health Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID 0000-0002-6133-8975
Nils OhdeInstitute of Clinical Nursing Science, Charité Universitätsmedizin, Berlin, Germany.ORCID 0009-0001-5200-1019
Carina BååthDepartment of Health Sciences, Faculty of Health, Science and Technology, Karlstad University, Karlstad, Sweden.ORCID 0000-0002-9608-336X
Ami HommelDepartment of Care Science, Malmö University, Malmö, Sweden.ORCID 0000-0002-6114-6535
Lisa HultinDepartment of Public Health and Caring Sciences, Upsalla University, Upsalla, Sweden.ORCID 0000-0001-8270-8560
Anna JosefsonSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID 0000-0002-7478-056X
Dimitri BeeckmanSwedish Centre for Skin and Wound Research (SCENTR), School of Health Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID 0000-0003-3080-8716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIncontinence-associated dermatitis (IAD) is irritant contact dermatitis and skin damage associated with prolonged skin contact with urine and/or faeces. Identifying prognostic factors for the development of IAD may improve management, facilitate prevention and inform future research. METHODS AND ANALYSIS: This protocol follows the guidelines of the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols. Prospective and retrospective observational studies or clinical trials in which prognostic factors associated with the development of IAD are described are eligible. There are no restrictions on study setting, time, language, participant characteristics or geographical regions. Reviews, editorials, commentaries, methodological articles, letters to the editor, cross-sectional and case-control studies, and case reports are excluded. MEDLINE, CINAHL, EMBASE and The Cochrane Library will be searched from inception until May 2023. Two independent reviewers will independently evaluate studies. The Quality in Prognostic Studies tool will be used to assess the risk of bias, and the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies-Prognostic Factors checklist will be used for data extraction of the included studies. Separate analyses will be conducted for each identified prognostic factor, with adjusted and unadjusted estimated measures analysed separately. Evidence will be summarised with a meta-analysis when possible, and narratively otherwise. The Q and I ETHICS AND DISSEMINATION: No ethical approval is needed since all data is already publicly accessible. The results of this work will be published in a peer-reviewed scientific journal.

Indexed as

DermatitisCross-Sectional StudiesHumansMeta-Analysis as TopicPrognosisProspective StudiesRetrospective StudiesSystematic Reviews as TopicPrognosisRisk FactorsSystematic ReviewWOUND MANAGEMENT

Identifiers

PMID37429690
PMCPMC10335443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.